These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33573998)

  • 1. Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapy.
    Murthy V; Bakshi G; Manjali JJ; Prakash G; Pal M; Joshi A; Dholakia K; Bhattacharjee A; Talole S; Puppalwar A; Srinivasan S; Panigrahi G; Salunkhe R; Menon S; Noronha V; Prabhash K; Krishnatry R
    Urol Oncol; 2021 Aug; 39(8):496.e9-496.e15. PubMed ID: 33573998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy.
    Sargos P; Baumann BC; Eapen L; Christodouleas J; Bahl A; Murthy V; Efstathiou J; Fonteyne V; Ballas L; Zaghloul M; Roubaud G; Orré M; Larré S
    Cancer Treat Rev; 2018 Nov; 70():88-97. PubMed ID: 30125800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer.
    Necchi A; Pond GR; Moschini M; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Vaishampayan U; Theodore C; Sridhar SS; Rosenberg JE; Bellmunt J; Gallina A; Colombo R; Montorsi F; Briganti A; Galsky MD
    Clin Genitourin Cancer; 2019 Feb; 17(1):7-14.e3. PubMed ID: 30292628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y; Gupta A; Shariat SF; Palapattu GS; Vazina A; Karakiewicz PI; Bastian PJ; Rogers CG; Amiel G; Perotte P; Schoenberg MP; Lerner SP; Sagalowsky AI
    J Clin Oncol; 2005 Sep; 23(27):6533-9. PubMed ID: 16116151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EORTC progression score identifies patients at high risk of cancer-specific mortality after radical cystectomy for secondary muscle-invasive bladder cancer.
    May M; Burger M; Brookman-May S; Stief CG; Fritsche HM; Roigas J; Zacharias M; Bader M; Mandel P; Gilfrich C; Seitz M; Tilki D
    Clin Genitourin Cancer; 2014 Aug; 12(4):278-86. PubMed ID: 24331576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer.
    Murthy V; Maitre P; Singh M; Pal M; Arora A; Pujari L; Kapoor A; Pandey H; Sharma R; Gudipudi D; Joshi A; Prabhash K; Noronha V; Menon S; Mehta P; Bakshi G; Prakash G
    Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e506-e515. PubMed ID: 37208232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer.
    Solanki AA; Martin B; Korpics M; Small C; Harkenrider MM; Mitin T
    Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):429-435. PubMed ID: 28242163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer.
    Mari A; Kimura S; Foerster B; Abufaraj M; D'Andrea D; Gust KM; Shariat SF
    Urol Oncol; 2018 Jun; 36(6):293-305. PubMed ID: 29685374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk-stratified approach to neoadjuvant chemotherapy in muscle-invasive bladder cancer: implications for patients classified with low-risk disease.
    Lyon TD; Frank I; Sharma V; Shah PH; Tollefson MK; Thompson RH; Karnes RJ; Thapa P; Cheville JC; Boorjian SA
    World J Urol; 2019 Aug; 37(8):1605-1613. PubMed ID: 30392012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy.
    Moschini M; Sharma V; Dell'oglio P; Cucchiara V; Gandaglia G; Cantiello F; Zattoni F; Pellucchi F; Briganti A; Damiano R; Montorsi F; Salonia A; Colombo R
    BJU Int; 2016 Apr; 117(4):604-10. PubMed ID: 25851271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.
    Orré M; Latorzeff I; Fléchon A; Roubaud G; Brouste V; Gaston R; Piéchaud T; Richaud P; Chapet O; Sargos P
    PLoS One; 2017; 12(4):e0174978. PubMed ID: 28384195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer].
    Pignot G; Sargos P
    Prog Urol; 2021 Mar; 31(3):158-168. PubMed ID: 33358467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.
    Novotny V; Froehner M; May M; Protzel C; Hergenröther K; Rink M; Chun FK; Fisch M; Roghmann F; Palisaar RJ; Noldus J; Gierth M; Fritsche HM; Burger M; Sikic D; Keck B; Wullich B; Nuhn P; Buchner A; Stief CG; Vallo S; Bartsch G; Haferkamp A; Bastian PJ; Hakenberg OW; Propping S; Aziz A
    World J Urol; 2015 Nov; 33(11):1753-61. PubMed ID: 25663359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
    J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Muscle-Invasive Urothelial Bladder Cancer After Radical Cystectomy.
    Salama A; Abdelmaksoud AM; Shawki A; Abdelbary A; Aboulkassem H
    Clin Genitourin Cancer; 2016 Feb; 14(1):e43-7. PubMed ID: 26363827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphovascular invasion is independently associated with bladder cancer recurrence and survival in patients with final stage T1 disease and negative lymph nodes after radical cystectomy.
    Tilki D; Shariat SF; Lotan Y; Rink M; Karakiewicz PI; Schoenberg MP; Lerner SP; Sonpavde G; Sagalowsky AI; Gupta A
    BJU Int; 2013 Jun; 111(8):1215-21. PubMed ID: 23181623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of carcinoma in situ in ureteral margins during radical cystectomy: A case-controlled study.
    Kerroumi S; Neuzillet Y; Soorojebally Y; Radulescu C; Talhi R; Taleb S; Herve CJ; Rouanne M; Abdou A; Bosset P; Bazzi A; Yousfi MJ; Lebret T
    Urol Oncol; 2021 Aug; 39(8):497.e1-497.e8. PubMed ID: 33579627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant Radiotherapy After Radical Cystectomy for Patients with High-risk Muscle-invasive Bladder Cancer: Results of a Multicentric Phase II Trial.
    Fonteyne V; Dirix P; Van Praet C; Berghen C; Albersen M; Junius S; Liefhooghe N; Noé L; De Meerleer G; Ost P; Villeirs G; Verbeke S; De Maeseneer D; Rammant E; Verghote F; Elhaseen E; De Man K; Decaestecker K
    Eur Urol Focus; 2022 Sep; 8(5):1238-1245. PubMed ID: 34893458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.